Richmond Timothy J.'s Form 4 filing
AbbVie Inc. (ABBV) · filed Mar 4, 2025
- Accession no.
- 0001415889-25-006580
- Filed
- Mar 4, 2025
- Trade date
- Feb 28-Mar 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.47M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richmond Timothy J.CIK 0001563523 | Officer (EVP, CHIEF HR OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common stock, $0.01 par value | FTax withholdingDisposed | −16,904 | $205.02 | −$3,465,658.08 | 27,380 | Direct | |
| Mar 3, 2025 | Common stock, $0.01 par value | SSaleDisposed | −5,677 | $209.80 | −$1,191,034.6 | 21,703 | Direct | |
| Mar 3, 2025 | Common stock, $0.01 par value | SSaleDisposed | −14,973 | $210.66 | −$3,154,212.18 | 6,730 | Direct | |
| Mar 3, 2025 | Common stock, $0.01 par value | SSaleDisposed | −600 | $211.32 | −$126,792 | 6,130 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.